Next Article in Journal
A Review of Bioinsecticidal Activity of Solanaceae Alkaloids
Next Article in Special Issue
PhTx3-4, a Spider Toxin Calcium Channel Blocker, Reduces NMDA-Induced Injury of the Retina
Previous Article in Journal
Botulinum toxin A for the Treatment of Overactive Bladder
Previous Article in Special Issue
Bee Venom Phospholipase A2: Yesterday’s Enemy Becomes Today’s Friend
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessFeature PaperArticle
Toxins 2016, 8(3), 61;

Paulistine—The Functional Duality of a Wasp Venom Peptide Toxin

Department of Biology/Center of Study of Social Insects, Institute of Biosciences, São Paulo State University (UNESP), Rio Claro 13506-900, SP, Brazil
Fundação Oswaldo Cruz—Health Ministry/Fiocruz Rondônia, Porto Velho 21040-900, RO, Brazil
Department of Clinical Analysis, Proteomic Center, Faculty of Pharmaceutical, Sciences, São Paulo State University (UNESP), Araraquara 14801-902, SP, Brazil
Author to whom correspondence should be addressed.
Academic Editor: Glenn F. King
Received: 9 December 2015 / Revised: 12 February 2016 / Accepted: 22 February 2016 / Published: 29 February 2016
(This article belongs to the Special Issue Arthropod Venoms)
Full-Text   |   PDF [3518 KB, uploaded 29 February 2016]   |  


It has been reported that Paulistine in the venom of the wasp Polybia paulista co-exists as two different forms: an oxidized form presenting a compact structure due to the presence of a disulfide bridge, which causes inflammation through an apparent interaction with receptors in the 5-lipoxygenase pathway, and a naturally reduced form (without the disulfide bridge) that exists in a linear conformation and which also causes hyperalgesia and acts in the cyclooxygenase type II pathway. The reduced peptide was acetamidomethylated (Acm-Paulistine) to stabilize this form, and it still maintained its typical inflammatory activity. Oxidized Paulistine docks onto PGHS2 (COX-2) molecules, blocking the access of oxygen to the heme group and inhibiting the inflammatory activity of Acm-Paulistine in the cyclooxygenase type II pathway. Docking simulations revealed that the site of the docking of Paulistine within the PGHS2 molecule is unusual among commercial inhibitors of the enzyme, with an affinity potentially much higher than those observed for traditional anti-inflammatory drugs. Therefore, Paulistine causes inflammatory activity at the level of the 5-lipooxygenase pathway and, in parallel, it competes with its reduced form in relation to the activation of the cyclooxygenase pathway. Thus, while the reduced Paulistine causes inflammation, its oxidized form is a potent inhibitor of this activity. View Full-Text
Keywords: wasp venom; inflammation; pain; peptide synthesis; molecular modeling; docking wasp venom; inflammation; pain; peptide synthesis; molecular modeling; docking

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Arcuri, H.A.; Gomes, P.C.; de Souza, B.M.; Dias, N.B.; Brigatte, P.; Stabeli, R.G.; Palma, M.S. Paulistine—The Functional Duality of a Wasp Venom Peptide Toxin. Toxins 2016, 8, 61.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top